Alyssa Verano, PhD Alyssa Verano is a Senior Scientist at AstraZeneca, where she is a medicinal chemist in the Oncology Chemistry group. Prior to joining AZ in 2020, Alyssa was a postdoctoral research fellow in Prof. Nathanael Gray’s lab where she worked on the synthesis and development of monovalent degraders of transcription factors and novel neo-substrates, as well as bispecific degraders to target kinases. Her research has also focused on the development of covalent inhibitors of several kinase targets. She completed her PhD training in organic chemistry and pharmacology under the supervision of Prof. Derek Tan at Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College. Her graduate research centered on the stereoselective synthesis and biological evaluation of spiroketal natural products. She is excited to remain a part of the DFCI Targeted Protein Degradation Webinar team while at AZ.